CYC.AX

Healthcare Medical Devices

Cyclopharm Limited

A$0.46

+0.02 +3.37% today

Price History

Not enough data

Key Stats

Market Cap

57.84M

Avg Volume

63,313

EPS

-A$0.16

52W High

A$1.29

52W Low

A$0.44

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-5.07

P/B Ratio

1.82

P/S Ratio

1.68

EV/EBITDA

-3.27

EV/Revenue

1.55

Margins

Gross Margin 56.5%

Operating Margin (48.0%)

Net Margin (53.2%)

EBITDA Margin (47.5%)

Growth & Returns

Revenue Growth (YoY)

13.6%

Return on Equity

(53.9%)

Return on Assets

(20.3%)

Liquidity & Leverage

Current Ratio

3.37

Quick Ratio

2.01

Debt / Equity

0.24

Total Cash

12.25M

Total Debt

7.80M

About

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally. The company operates Technegas which offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. It is also involved in the research and development; and distribution of third-party products to the diagnostic imaging sector. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is based in Kingsgrove, Australia.